Cvs Health Corp Stock Alpha and Beta Analysis

CVS Stock  USD 59.96  0.95  1.61%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as CVS Health Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in CVS Health over a specified time horizon. Remember, high CVS Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to CVS Health's market risk premium analysis include:
Beta
1.56
Alpha
(0.14)
Risk
2.6
Sharpe Ratio
0.0478
Expected Return
0.12
Please note that although CVS Health alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, CVS Health did 0.14  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of CVS Health Corp stock's relative risk over its benchmark. CVS Health Corp has a beta of 1.56  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CVS Health will likely underperform. At this time, CVS Health's Book Value Per Share is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 91.1 B in 2024, despite the fact that Tangible Book Value Per Share is likely to grow to (32.43).

CVS Health Quarterly Cash And Equivalents

13.04 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out CVS Health Backtesting, CVS Health Valuation, CVS Health Correlation, CVS Health Hype Analysis, CVS Health Volatility, CVS Health History and analyze CVS Health Performance.

CVS Health Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. CVS Health market risk premium is the additional return an investor will receive from holding CVS Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CVS Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate CVS Health's performance over market.
α-0.14   β1.56

CVS Health expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of CVS Health's Buy-and-hold return. Our buy-and-hold chart shows how CVS Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

CVS Health Market Price Analysis

Market price analysis indicators help investors to evaluate how CVS Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CVS Health shares will generate the highest return on investment. By understating and applying CVS Health stock market price indicators, traders can identify CVS Health position entry and exit signals to maximize returns.

CVS Health Return and Market Media

The median price of CVS Health for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 57.19 with a coefficient of variation of 5.68. The daily time series for the period is distributed with a sample standard deviation of 3.32, arithmetic mean of 58.44, and mean deviation of 2.63. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
 
CVS Health dividend paid on 1st of November 2024
11/01/2024
1
New CEO at CVS begins to build his team with a goal of reviving the struggling health care giant
11/06/2024
2
Jim Cramer Says The New Team At CVS Health Corporation , Which Owns Aetna, Just Got A Gigantic Break
11/12/2024
3
J. W. Coons Advisors LLC Sells 195 Shares of CVS Health Co.
11/18/2024
4
CVS Health Options Trading A Deep Dive into Market Sentiment
11/19/2024
5
MTM Investment Management LLC Sells 579 Shares of CVS Health Co.
11/20/2024
6
Acquisition by Fernando Aguirre of 2364 shares of CVS Health at 57.1 subject to Rule 16b-3
11/21/2024
7
Charles Schwab Investment Management Inc. Raises Stock Position in CVS Health Co.
11/22/2024
8
CVS to close Tampa specialty pharmacy, cut over 50 jobs
11/26/2024

About CVS Health Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including CVS or other stocks. Alpha measures the amount that position in CVS Health Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2023 2024 (projected)
Dividend Yield0.01930.03090.0243
Price To Sales Ratio0.470.280.27

CVS Health Upcoming Company Events

As portrayed in its financial statements, the presentation of CVS Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CVS Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of CVS Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of CVS Health. Please utilize our Beneish M Score to check the likelihood of CVS Health's management manipulating its earnings.
7th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with CVS Health

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for CVS Stock Analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.